Vulvovaginal Atrophy Not Yet Recruiting Phase 2 Trials for Visnadine (DB13355)

Also known as: Vulvovaginal atrophy / Vaginal Atrophy / Atrophic vulvovaginitis / Vulvovaginitis atrophy / Vulvovaginitis atrophic / Senile vulvovaginitis

IndicationStatusPhase
DBCOND0046622 (Vulvovaginal Atrophy)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03281655Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal WomenTreatment